GlassScriptPhysician profile
Julia Dafforn
NPI 1235868860
$965.76
in general payments reported to CMS, 2019-2025
11 companies · $317 in 2025
The $317 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $409 · 2024: $240 · 2025: $317.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $966.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $965.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $230.82 | 2023 | Hammerlock, Na |
| Kerecis Limited | $149.99 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Organogenesis INC. | $114.68 | 2024 | Puraply Wound Matrix, Apligraf, Novachor |
| Integra Lifesciences Corporation | $114.05 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Stryker Corporation | $86.49 | 2023-2025 | Asnis, Ortholoc 2 Lapifuse |
| Acumed LLC | $85.58 | 2024 | Osteomed, Acumed |
| Smith+Nephew, INC. | $74.77 | 2023 | Grafix Pl, Stravix Pl, Collagenase Santyl |
| Acera Surgical, INC. | $36.19 | 2023-2024 | Restrata Wound Matrix |
| Medline Industries LP | $28.80 | 2023 | |
| Linvatec Corporation | $24.97 | 2024 | Biobrace 23mm |
| Vertex Pharmaceuticals Incorporated | $19.42 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julia Dafforn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.